Question explored with the scientific record
What causes very high blood calcium levels
The main causes of very high blood calcium are overactive parathyroid glands, certain cancers, and excess vitamin D activity.
The most common cause is primary hyperparathyroidism, where a benign adenoma (88-90% of cases) or hyperplasia (5-7%) makes the parathyroid glands release too much PTH [6]. This pulls calcium from bone and reduces kidney excretion. A single adenoma can push serum calcium above 12 mg/dL and PTH into the hundreds [5, 7]. One case report documented calcium at 16.3 mg/dL with PTH of 742 pg/mL [5].
Cancer is the second major cause, often through a hormone called PTH-related peptide (PTHrP) that mimics PTH [8, 10]. Squamous cell cancers of the lung, head and neck, and bladder are common culprits [8]. One case of penile cancer produced calcium of 15.5 mg/dL [10]; a lymphoma case hit 19.2 mg/dL [9]. Some lymphomas and granulomatous diseases (sarcoidosis, tuberculosis) cause hypercalcemia by making too much active vitamin D (1,25-dihydroxyvitamin D) outside the kidney [11, 16, 17]. In sarcoidosis, the granulomas themselves produce the enzyme that activates vitamin D [16, 17].
Vitamin D toxicity from massive supplementation is another route. Doses of 50,000 to over 2 million IU per day have produced calcium levels between 11.1 and 23.1 mg/dL [15]. A 3-month-old infant given 1.2 million IU cumulative reached 18.5 mg/dL [12]. The toxicity threshold is roughly a 25(OH)D level above 750 nmol/L [14].
Less common causes include familial hypocalciuric hypercalcemia (FHH), a benign genetic condition where the calcium sensor is less sensitive, leading to mild hypercalcemia with low urine calcium [1, 2, 3, 4]. Immobilization, thiazide diuretics, and vitamin A toxicity can also raise calcium [13, 16].
| Cause | Typical Mechanism | Example Calcium Level |
|---|---|---|
| Primary hyperparathyroidism | Excess PTH from adenoma/hyperplasia | 12-16 mg/dL [5, 7] |
| Malignancy (humoral) | PTHrP from solid tumors | 15.5 mg/dL [10] |
| Lymphoma/granulomatous | Excess 1,25(OH)2D from immune cells | 17-19 mg/dL [9, 11] |
| Vitamin D toxicity | Massive intake overwhelms metabolism | 11-23 mg/dL [12, 15] |
| Familial hypocalciuric hypercalcemia | CaSR mutation, low urine calcium | 10.6-11.3 mg/dL [3] |
My call: the evidence clearly shows that very high calcium is driven by three main mechanisms—excess PTH, PTHrP from cancer, or unregulated vitamin D activation—and the specific cause determines treatment. Confidence: high.
Sources used 17
-
Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism
This study compares plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in patients with familial hypocalciuric hypercalcemia and primary hyperparathyroidism, revealing significant differences in vitamin D metabolism and parathyroid hormone lev…
DOI: 10.1530/EJE-08-0440 -
Maximal Urine-Concentrating Ability: Familial Hypocalciuric Hypercalcemia Versus Typical Primary Hyperparathyroidism
A comparative study of urine-concentrating ability in 50 hypercalcemic patients showing that familial hypocalciuric hypercalcemia preserves greater maximal urinary osmolality than typical primary hyperparathyroidism, with distinct relationships to urinary cAMP and calcium excret…
DOI: 10.1210/jcem-52-4-736 -
Plasma Intact Parathyroid Hormone (PTH) and PTH-Related Peptide in Familial Benign Hypercalcemia: Greater Responsiveness to Endogenous PTH Than in Primary Hyperparathyroidism*
This study investigates the differences in plasma intact parathyroid hormone (PTH) and PTH-related peptide (PTHrP) levels in patients with familial benign hypercalcemia (FBH) compared to those with primary hyperparathyroidism (1°HPT), revealing that FBH patients exhibit lower PT…
DOI: 10.1210/jcem-72-3-541 -
Familial Hypocalciuric Hypercalcemia: Recognition Among Patients Referred After Unsuccessful Parathyroid Exploration
This study identifies familial hypocalciuric hypercalcemia in 9% of patients referred after unsuccessful parathyroid surgery, highlighting the importance of urine calcium excretion measurements for accurate diagnosis.
DOI: 10.7326/0003-4819-92-3-351 -
Aggressive gyriform calcifications and seizures after ischemia stroke in a patient with primary hyperparathyroidism
This is a single-patient case report of a 59-year-old man with primary hyperparathyroidism who developed ischemic stroke followed by aggressive gyriform brain calcifications and seizures, likely linked to prolonged hypercalcemia and impaired renal function, with parathyroidectom…
DOI: 10.1093/qjmed/hcu010 -
Primary hyperparathyroidism
A comprehensive narrative review of primary hyperparathyroidism (PHPT) detailing its epidemiology, etiology, pathophysiology, clinical manifestations across bone, kidney, rheumatologic and cardiovascular systems, diagnostic approaches, imaging modalities, and management strategi…
DOI: 10.1016/j.berh.2020.101514 -
Peptic Ulcer Perforation as the First Manifestation of Previously Unknown Primary Hyperparathyroidism
A rare case where perforated duodenal ulcer was the first manifestation of previously unknown primary hyperparathyroidism, with emergency parathyroidectomy normalizing calcium/PTH and leading to ulcer healing.
DOI: 10.1159/000104224 -
HYPERCALCEMIA OF MALIGNANCY
This study reviews the clinical and biochemical features of malignancy-associated hypercalcemia, distinguishing between local osteolytic hypercalcemia and humoral hypercalcemia of malignancy, and discusses their pathogenesis and management strategies.
DOI: 10.1146/annurev.me.38.020187.001325 -
Polyuria and Abdominal Pain in a Young Jamaican Woman
This case study presents a young Jamaican woman with polyuria and abdominal pain, ultimately diagnosed with hypercalcemia of malignancy associated with adult T-cell leukemia/lymphoma (ATLL), highlighting the diagnostic challenges and treatment approaches for this condition.
DOI: 10.1309/04d3-n0hw-v9cg-ugt1 -
PARATHYROID HORMONE RELATED PROTEIN PRODUCING PENILE CANCER
This case report documents a 53-year-old man with advanced penile squamous cell carcinoma associated with humoral hypercalcemia of malignancy due to parathyroid hormone-related protein production, confirmed by immunohistochemistry.
DOI: 10.1016/s0022-5347(05)65428-6 -
Elevations in Circulating 1,25-Dihydroxyvitamin D in Three Patients with Lymphoma-Associated Hypercalcemia*
Three patients with lymphoma-associated hypercalcemia exhibited elevated circulating 1,25-dihydroxyvitamin D that rapidly declined after tumor removal or dexamethasone, suggesting humoral production of 1,25-(OH)2D by lymphoma as a mediator of hypercalcemia, with evidence against…
DOI: 10.1210/jcem-60-1-29 -
Oral Bisphosphonate Therapy for Vitamin D Intoxication of the Infant
A case report describing a 3-month-old (infant) with severe vitamin D intoxication and hypercalcemia successfully treated with short-term oral alendronate, leading to rapid calcium normalization and resolution of symptoms with no nephrocalcinosis.
DOI: 10.1542/peds.111.4.899 -
Hypercalcemia in children: An overview
This feature article provides a comprehensive overview of pediatric hypercalcemia, detailing the major etiologies (notably calcium-sensing receptor–related familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism, vitamin D–related causes, immobilization, and…
DOI: 10.1111/j.1442-200x.1997.tb03624.x -
Pharmacokinetics of vitamin D toxicity
Hypervitaminosis D toxicity appears linked to extremely high 25(OH)D levels that may overwhelm DBP binding and raise free metabolites, with a practical toxicity threshold near 750 nmol/L of 25(OH)D and limited, inconsistent elevations of the active hormone 1α,25(OH)2D3.
DOI: 10.1093/ajcn/88.2.582s -
Development of Vitamin D Toxicity from Overcorrection of Vitamin D Deficiency: A Review of Case Reports
This review of case reports describes vitamin D toxicity arising from excessive supplementation—doses up to 2,604,000 IU/day—with hypercalcemia, elevated 25(OH)D, and renal dysfunction; patients generally recovered after stopping supplementation.
DOI: 10.3390/nu10080953 -
Parathyroid hormone independent hypercalcemia in adults
A comprehensive narrative review of non–parathyroid hypercalcemia in adults, covering etiologies (including malignancy-associated and vitamin D–mediated causes), underlying mechanisms, diagnostic approaches, treatment strategies, and areas for future research.
DOI: 10.1016/j.beem.2018.06.005 -
Sarcoidosis: The Nephrologist’s Perspective
This paper reviews the renal manifestations of sarcoidosis, focusing on hypercalcemia, hypercalciuria, and granulomatous interstitial nephritis, and discusses their clinical implications and treatment options.
DOI: 10.1053/j.ajkd.2006.07.022